Stevanato Group S.p.A. (NYSE:STVN) Receives Average Recommendation of “Moderate Buy” from Analysts

Shares of Stevanato Group S.p.A. (NYSE:STVN) have earned an average recommendation of “Moderate Buy” from the six ratings firms that are currently covering the firm, MarketBeat Ratings reports. Two analysts have rated the stock with a hold recommendation, three have given a buy recommendation and one has given a strong buy recommendation to the company.

Separately, William Blair reiterated an “outperform” rating on shares of Stevanato Group in a report on Monday, June 30th.

Institutional Trading of Stevanato Group

Hedge funds and other institutional investors have recently made changes to their positions in the business. Bessemer Group Inc. raised its holdings in shares of Stevanato Group by 14,623.3% in the first quarter. Bessemer Group Inc. now owns 13,251 shares of the company’s stock valued at $270,000 after purchasing an additional 13,161 shares during the last quarter. Palisade Capital Management LP grew its stake in shares of Stevanato Group by 52.0% in the first quarter. Palisade Capital Management LP now owns 91,431 shares of the company’s stock valued at $1,867,000 after buying an additional 31,283 shares in the last quarter. D. E. Shaw & Co. Inc. bought a new position in shares of Stevanato Group in the fourth quarter valued at $281,000. Envestnet Asset Management Inc. grew its stake in shares of Stevanato Group by 16.9% in the first quarter. Envestnet Asset Management Inc. now owns 162,770 shares of the company’s stock valued at $3,324,000 after buying an additional 23,545 shares in the last quarter. Finally, Yarbrough Capital LLC bought a new position in shares of Stevanato Group in the first quarter valued at $329,000.

Stevanato Group Price Performance

NYSE STVN opened at €22.48 on Wednesday. The company has a quick ratio of 1.22, a current ratio of 1.79 and a debt-to-equity ratio of 0.25. Stevanato Group has a 12-month low of €17.12 and a 12-month high of €28.00. The company has a market capitalization of $6.81 billion, a PE ratio of 41.63, a price-to-earnings-growth ratio of 2.13 and a beta of 0.55. The firm’s 50 day moving average is €24.42 and its 200-day moving average is €22.49.

About Stevanato Group

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.